Report Company Directory

MANGOCEUTICALS INC

• Mangoceuticals, Inc. Announces Closing of $2.5 Million Registered Direct and Private Placements by GlobeNewsWire
• Mangoceuticals, Inc. Announces Partnership with The Cube Group to Launch Up To $100 Million Solana-Focused Digital Asset Treasury (DAT) Strategy by GlobeNewsWire
• Mangoceuticals, Inc. Announces $2.5 Million Registered Direct and Private Placements Priced at the Market Under Nasdaq Rules by GlobeNewsWire
• Mangoceuticals Provides Clarification on Launch of Branded GLP-1 Weight-Management Programs by GlobeNewsWire
• Mangoceuticals Partners with Eli Lilly and Novo Nordisk to Deliver Affordable Access to Zepbound and Wegovy for Obesity Management by GlobeNewsWire
• Mangoceuticals’ Patented MGX-0024 Delivers 100% Respiratory Survival in Poultry Studies Signaling Strong Potential Defense Against Spread of Avian Flu by GlobeNewsWire
• Mangoceuticals Announces Strategic Entry into High Growth Pouch Industry Through Acquisition of Smokeless Technology IP and Appointment of Tim Corkum Ex Philip Morris Executive to Lead High Growth Pouch Division by GlobeNewsWire
• Mangoceuticals Expands into $33 Billion Addressable Diabetes Market Through its Exclusive Rights to Market and Sell Patented and Clinically Proven Diabetinol® in the USA and Canada by GlobeNewsWire
• Mangoceuticals Announces the Launch of “PeachesRx” - a Women's Telehealth Brand Focused on Personalized Wellness and GLP-1 Weight Loss Treatments by GlobeNewsWire
• Mangoceuticals Advances Antiviral Research on its Patented Respiratory Illness Prevention Technology With New Study Targeting Avian Flu in Poultry Using a Non-Invasive, Non-Pharmaceutical Water-Based Solution by GlobeNewsWire

Mangold AB

• Ford Equity International Rating and Forecast Report by Ford Equity Research

Manhattan Associates Inc.

• William Blair’s 2026 Top Picks Discussions: December 8–12, 2025 by William Blair
• William Blair’s 2026 Top Picks Discussions: December 8–12, 2025 by William Blair
• Model Update After Earnings Review by William Blair
• William Blair’s 2026 Top Picks Discussions: December 8–12, 2025 by William Blair
• Reminder: Booth Crawl at AWS re:Invent by William Blair
• William Blair’s 2026 Top Picks Discussions: December 8–12, 2025 by William Blair
• The Age of Embedded Intelligence: Vertical Software’s Foundational Role in an Agentic World by William Blair
• Booth Crawl at AWS re:Invent by William Blair
• Some Bookings Seasonality, but Full-Year RPO and Initial 2026 Outlook Support Sustained Momentum by William Blair
• Equity Research Rewind: Third Quarter 2025 by William Blair

Manhattan Bridge Capital Inc.

• Manhattan Bridge Capital, Inc. Announces the Buy-back of up to 100,000 of its Common Shares by GlobeNewsWire
• Manhattan Bridge Capital, Inc. Declares Quarterly Dividend by GlobeNewsWire
• Manhattan Bridge Capital, Inc. Reports Third Quarter 2025 Results by GlobeNewsWire
• Manhattan Bridge Capital, Inc. Announces Payment of Quarterly Dividend by GlobeNewsWire
• Manhattan Bridge Capital, Inc. Declares Quarterly Dividend by GlobeNewsWire
• Manhattan Bridge Capital, Inc. Reports Second Quarter Results for 2025 by GlobeNewsWire
• Manhattan Bridge Capital, Inc. Announces Payment of Quarterly Dividend by GlobeNewsWire
• Manhattan Bridge Capital, Inc. Reports First Quarter Results for 2025 by GlobeNewsWire
• Manhattan Bridge Capital, Inc. Declares Quarterly Dividend by GlobeNewsWire
• Manhattan Bridge Capital, Inc. Announces Payment of Quarterly Dividend by GlobeNewsWire

MANHATTAN CMB GLOBAL SICAV